Loading...
01/11 16:21
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents mixed signals: positive aspects include strong AI product growth, improved net income, and a sustainable G&A reduction. However, the company faces challenges with transaction revenue, unclear AI rights product performance, and limited visibility in the transaction segment. While adjusted EBITDA and cash flow improved, the market may remain cautious due to the uncertainties in guidance and execution. The overall sentiment is neutral, as the positive financial performance is counterbalanced by potential risks and uncertainties in future growth.
Total Revenue $12.3 million, up from $12 million in the first quarter of fiscal 2025, representing a year-over-year increase. The growth was driven by a net increase in platform deployments, upsells, and cross-sells into the existing customer base.
Platform Subscription Revenue $5.1 million, an 18% increase year-over-year. This growth was primarily due to a net increase in platform deployments and upsells/cross-sells into the existing customer base.
Annual Recurring Revenue (ARR) $21.3 million, up 21% year-over-year. This includes $14.8 million in B2B ARR and $6.5 million in normalized ARR from Scite's B2C subscribers. The growth was driven by strong B2B performance and incremental ARR growth.
Incremental ARR $375,000, a 92% increase compared to $195,000 in the prior year quarter. B2B growth was especially strong at $561,000, up from $128,000 last year. The increase was attributed to improved sales execution and new platform sales.
Transaction Revenue $7.2 million, down from $7.7 million in the prior year quarter, reflecting a decline of approximately 6.5%. The decline was attributed to economic conditions, changes in research priorities, and reduced revenue from specific large customers.
Gross Profit $6.2 million, an 8% increase year-over-year. Gross margin improved to 50.6%, a 270 basis point increase, driven by a revenue mix shift towards higher-margin platform business and expanding gross margins in the platform segment.
Platform Business Gross Margin 88.1%, a 70 basis point increase year-over-year. The improvement was due to slower growth in labor and hosting costs compared to revenue growth.
Transaction Business Gross Margin 23.8%, down from 25.7% in the prior year quarter. The decline was due to lower copyright margins and reduced fixed cost leverage from a smaller revenue base.
Operating Expenses $5.3 million, up from $5.1 million in the prior year quarter. The increase was driven by higher sales and marketing expenses, partially offset by lower general and administrative and stock-based compensation expenses.
Net Income $749,000 or $0.02 per diluted share, compared to $669,000 or $0.02 per diluted share in the prior year quarter. The increase was attributed to improved operational performance.
Adjusted EBITDA $1.5 million, a 16% increase from $1.3 million in the prior year quarter. This was the second-best adjusted EBITDA performance in company history, driven by strong revenue growth and cost management.
Cash and Cash Equivalents $12 million as of September 30, 2025, compared to $12.2 million on June 30, 2025. Despite a $1.3 million cash outlay for the Scite earnout, operational cash flow remained strong.
Cash Flow from Operations $1.1 million, a 31% increase from $843,000 in the first quarter of fiscal 2025. The increase was due to healthy operational cash flow.
AI Rights Offering: Launched an AI rights offering in Article Galaxy called RightsDel, allowing researchers to acquire AI rights for documents they own. Revenue is shared between publishers and Research Solutions.
AI Gateway Product: Working with publishers to offer an AI gateway product based on Scite, enabling customers to purchase AI rights for all of a publisher's content. This creates ARR upsell opportunities and positions Research Solutions as an AI technology partner.
B2B ARR Growth: B2B ARR grew by $561,000 in the quarter, up from $128,000 last year, driven by strong new logo sales and upsells.
B2C to B2B Transition: Significant increase in B2C leads transitioning to B2B business, with pipeline growing from $50,000 in Q1 FY '25 to over $1 million in Q1 FY '26.
Revenue Growth: Total revenue for Q1 FY '26 was $12.3 million, up from $12 million in Q1 FY '25. Platform subscription revenue increased by 18% to $5.1 million.
Gross Margin Improvement: Gross margin improved to 50.6%, up 270 basis points from the prior year, driven by a revenue mix shift towards higher-margin platform business.
Cash Flow: Operational cash flow increased by 31% to $1.1 million, despite a $1.3 million cash outlay for the Scite earnout.
AI Integration: Focused on integrating AI into research tools, including AI rights and AI-specific usage metrics, to align with market trends and create new revenue streams.
Retention and Upsell Strategy: Improving customer retention and upsell through proactive engagement, better health scoring, and product enhancements.
Transaction Revenue Decline: Transaction revenue for the first quarter was $7.2 million compared to $7.7 million in the prior year quarter, reflecting a decline. This decline is expected to continue to be challenging minimally through the first half of fiscal 2026, driven by economic environment changes and shifts in research priorities of key customers.
Customer Churn: The corporate segment is experiencing a decline, with about 60% of the decline coming from churned accounts. Additionally, two very large customers are buying less year-over-year due to economic conditions or changes in research priorities.
B2C ARR Decline: There was a decline in B2C ARR, attributed to seasonally challenging times for B2C growth. This could impact the overall revenue mix and growth trajectory.
Gross Margin Pressure in Transaction Business: Gross margin in the transaction business decreased to 23.8% from 25.7% in the prior year quarter, primarily due to lower copyright margins and reduced fixed cost leverage from a smaller revenue base.
Economic Environment Impact: The economic environment is cited as a reason for reduced spending by some large customers, which is impacting transaction revenue and overall growth.
Retention and Upsell Challenges: The company is facing challenges in improving retention and upsell performance, requiring better customer engagement and product improvements to address churn and drive growth.
Revenue Expectations: The company expects to see new ARR growth materially higher than the incremental sales investments made, with a payback period of a little over 1 year on products that have a 6- to 8-year lifetime value. The company also anticipates outperformance in fiscal 2026 compared to fiscal 2025 in each of the remaining quarters, aiming for another record year with expanded cash flows.
Margin Projections: The company expects continued expansion in gross margins, particularly in the Platforms business, as labor and hosting costs increase at a slower pace than revenues. The goal is to progress toward a weighted Rule of 40.
Seasonality and EBITDA Trends: The company anticipates a dip in adjusted EBITDA between Q1 and Q2, but expects the dip to be less pronounced than last year, with potential sequential growth in EBITDA between Q1 and Q2. Q3 and Q4 are expected to be the strongest quarters for adjusted EBITDA.
Market Trends and Strategic Plans: The company is focusing on AI-based products and expects to see increased traction in B2B strategic revenues from B2C channels. It is also working on AI rights offerings and AI gateway products to monetize AI usage of content, which could lead to increased platform seat revenues, cross-sells, and decreased churn. Additionally, the company is addressing the lack of AI usage metrics in the industry by introducing AI-specific usage metrics.
Operational Changes: The company plans to improve Scite B2C net ARR growth through product improvements, marketing, and sales messaging. It also aims to enhance ARR growth and ASP growth through better sales execution and product improvements, improve retention and upsell performance through proactive customer engagement, and innovate in the transaction business to achieve flat to slow growth.
The selected topic was not discussed during the call.
The earnings call presents mixed signals: positive aspects include strong AI product growth, improved net income, and a sustainable G&A reduction. However, the company faces challenges with transaction revenue, unclear AI rights product performance, and limited visibility in the transaction segment. While adjusted EBITDA and cash flow improved, the market may remain cautious due to the uncertainties in guidance and execution. The overall sentiment is neutral, as the positive financial performance is counterbalanced by potential risks and uncertainties in future growth.
The earnings call shows strong financial performance with record high adjusted EBITDA and cash flow, a significant improvement in net income, and a growing cash balance. The Q&A highlights strategic partnerships and product improvements, particularly in the API strategy and academic segment, which are expected to drive future growth. Despite a slight decline in transaction revenue, the overall outlook is positive with expectations of continued growth and margin improvement. The absence of clear guidance on operating expenses is a minor concern, but overall sentiment remains positive.
The company shows strong financial performance with record-high adjusted EBITDA and cash flow, increased ARR, and improved gross margins. Despite competitive pressures and economic concerns, the transition to SaaS revenue and strategic investments in sales and marketing are promising. The Q&A highlighted proactive growth strategies and AI utilization, although some responses lacked clarity. The absence of shareholder return programs is a minor negative. Overall, the positive financial metrics and optimistic future guidance suggest a positive stock price movement.
The earnings call summary indicates strong product development, strategic acquisitions, and a positive outlook on profitability and cash flow. The Q&A section reveals management's confidence in future growth, especially in the academic segment, and a strong competitive position. Despite some concerns about Resolute's performance and cost management, the overall sentiment is positive, supported by optimistic guidance and strategic initiatives. The absence of major negative factors and the emphasis on growth and profitability suggest a positive stock price movement in the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
